Find a Trial
Trial Summary
| Protocol No. | C16-174 | ||
|---|---|---|---|
| Status | OPEN TO ACCRUAL | ||
| Principal Investigator | Adra, Nabil | ||
| Scope | National | ||
| Phase | Phase III | ||
| Age Group | Adult | ||
| Title | DORA Trial: Phase III Trial of Docetaxel vs. Docetaxel and Radium-223 for Metastatic Castration-Resistant Prostate Cancer (mCRPC) | ||
| Description | The purpose of this study is to compare any good and bad effects of using radium-223 along with docetaxel chemotherapy treatment versus using docetaxel alone. | ||
| Key Eligibility | In order to be eligible to take part in this trial, patients must meet the following criteria: | ||
| Applicable Disease Sites | Prostate | ||
| Participating Institutions | Indiana University (IU) | ||
| Treatment Type | Treatment | ||
| Contact | Phone: (317) 278-5632 Email: iutrials@iu.edu | ||